| Product | Therapeutic category | Dosage form | Strength |
|---|---|---|---|
| Azacitidine | Bone marrow treatment, juvenile myelomonocytic leukemia | Injection | 100 mg/vial |
| Bleomycin injection | Multiple cancer treatment | Injection | 15 IU/vial |
| Bortezomib lyophilized powder | Multiple myeloma | Injection | 1/2.5/3/3.5 mg |
| Calcium leucovorin | Treatment of megaloblastic anaemia | Injection | 50/100/200/350 mg |
| Carboplatin | Advanced ovarian carcinoma | Injection | 50 mg/5 mL 150 mg/15 mL 450 mg/45 mL 600 mg/60 mL |
| Cisplatin | Advanced testicular, ovarian, bladder cancer | Injection | 10 mg/50 mg |
| Cytarabine | Blood cancer | Injection | (20 mg/mL) 100mg/mL, 100mg/vial, 500 mg/vial,1g/2g/vial |
| Dacarbazine | Metastatic malignant melanoma | Injection | 200 mg/vial |
| Docetaxel | Multiple cancer treatment | Injection | 20 mg/2 mL, 80 mg/8 mL, 160 mg/16 mL |
| Doxorubicin | Adjuvant breast cancer / Other cancers | Injection | 10 mg/5 mL |
| Epirubicin lyophilized powder | Breast cancer | Injection | 50 mg/200 mg |
| Etoposide | Refractory testicular tumor / Small cell lung cancer | Injection | 100 mg |
| Fludarabine phosphate | B-cell chronic lymphocytic leukemia (CLL) | Injection | 50 mg/2 mL (25 mg/mL) |
| Fosaprepitant dimeglumine | Antiemetic | Injection | 150 mg |
| Fulvestrant | Breast cancer | Injection | 250 mg/ 5 mL 50mg/mL |
| Gemcitabine | Multiple cancer treatment | Injection | 200 mg/2 mL 100 mg/1mL |
| Methotrexate | Acute lymphoblastic leukemia / Meningeal leukemia | Injection | With Preservative - 50 mg/2 mL Preservative-free - 1 g/40 mL |
| Oxaliplatin | Treatment of advanced colorectal cancer | Injection | 50 mg or 100 mg |
| Paclitaxel | Advanced carcinoma of the ovary | Injection | 30mg/5mL, 100 mg/16.7 mL, 300 mg/50 mL |
| Pemetrexed | Non-squamous non-small cell lung cancer (NSCLC) | Injection | 100 mg/4 mL, 500 mg/20 mL, 1,000 mg/40 mL |
| Plerixafor | Non-hodgkin's lymphoma (NHL) and multiple myeloma (MM) | Injection | 24mg/1.2mL (20mg/mL) |
| Vincristine | Acute leukemia | Injection | 1 mg/1 mL, 2 mg/2 mL |